This article provides a comprehensive analysis of the critical differences between IC50 values obtained from biochemical and cellular assays, a common challenge in drug discovery.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on validating the specificity and selectivity of analytical methods.
This article provides a systematic comparison between spectrophotometric and Ultra-Fast Liquid Chromatography with Diode Array Detection (UFLC-DAD) methods for pharmaceutical analysis.
This article provides a comprehensive analysis of comparative screening methodologies for developing specific Signal Transducer and Activator of Transcription (STAT) inhibitors.
This article addresses the critical challenge of reconciling discrepancies in enzyme kinetic data obtained from simplified in vitro assays versus complex cellular environments.
This article provides a comprehensive guide for researchers and drug development professionals on replicating the intracellular ionic environment in vitro.
This article provides a comprehensive guide for researchers and drug development professionals on the critical, yet often overlooked, differences between intracellular and extracellular physicochemical environments.
This article provides a comprehensive resource for researchers and drug development professionals grappling with the significant effects of molecular crowding on protein-ligand interactions.
This article addresses a critical challenge in biomedical research: the persistent discrepancy between biochemical assay (BcA) and cell-based assay (CBA) results, which often delays drug development.
Inconsistencies between biochemical assay (BcA) and cell-based assay (CBA) data are a major hurdle in drug discovery, often leading to delayed projects and misinterpreted structure-activity relationships.